Risperidone
DrugBank ID: DB00734
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 4 |
| DL Only | 46 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| manic bipolar affective disorder | 0.9998 | KG+DL |
| autism spectrum disorder | 0.9978 | KG+DL |
| autism susceptibility 1 | 0.9977 | KG+DL |
| gaze palsy, familial horizontal, with progressive scoliosis | 0.9976 | DL |
| asperger syndrome, susceptibility to | 0.9974 | DL |
| amelocerebrohypohidrotic syndrome | 0.9969 | DL |
| Phelan-McDermid syndrome | 0.9959 | DL |
| trichotillomania | 0.9951 | DL |
| major affective disorder | 0.9911 | DL |
| bipolar disorder | 0.9889 | DL |
| Tourette syndrome | 0.9876 | DL |
| intellectual disability | 0.9872 | DL |
| autism, susceptibility to | 0.9865 | DL |
| chromosome 15q11.2 deletion syndrome | 0.9859 | DL |
| 16q24.3 microdeletion syndrome | 0.9859 | DL |
| schizophrenia | 0.9855 | DL |
| occipital pachygyria and polymicrogyria | 0.9832 | DL |
| attention deficit-hyperactivity disorder | 0.9826 | DL |
| distal 17p13.3 microdeletion syndrome | 0.9820 | DL |
| epsilon-trimethyllysine hydroxylase deficiency | 0.9814 | DL |
| Malan overgrowth syndrome | 0.9810 | DL |
| faciodigitogenital syndrome | 0.9779 | DL |
| hydranencephaly (disease) | 0.9778 | DL |
| retinal dystrophy with or without extraocular anomalies | 0.9740 | DL |
| myopia X-linked | 0.9738 | DL |
| polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 0.9728 | DL |
| myopia 26, X-linked, female-limited | 0.9719 | DL |
| congenital disorder of glycosylation with defective fucosylation | 0.9719 | DL |
| syndromic myopia | 0.9711 | DL |
| hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | 0.9704 | DL |
| hypotonia, infantile, with psychomotor retardation and characteristic facies | 0.9691 | DL |
| trigeminal nerve neoplasm | 0.9632 | DL |
| Charcot-Marie-Tooth disease, demyelinating, type 1G | 0.9630 | DL |
| atypical glycine encephalopathy | 0.9620 | DL |
| attention deficit hyperactivity disorder, inattentive type | 0.9603 | DL |
| chondromyxoid fibroma | 0.9459 | DL |
| autism (disease) | 0.9442 | KG+DL |
| specific developmental disorder | 0.9418 | DL |
| restless legs syndrome | 0.9396 | DL |
| pyruvate carboxylase deficiency disease | 0.9146 | DL |
| myofascial pain syndrome | 0.9093 | DL |
| childhood apraxia of speech | 0.8701 | DL |
| striatal degeneration, autosomal dominant | 0.8318 | DL |
| 46,XY disorder of sex development due to testicular steroidogenesis defect | 0.7824 | DL |
| pervasive developmental disorder - not otherwise specified | 0.7771 | DL |
| visual epilepsy | 0.7711 | DL |
| transient tic disorder | 0.7691 | DL |
| mixed anxiety and depressive disorder | 0.7572 | DL |
| longitudinal vaginal septum | 0.7502 | DL |
| transverse vaginal septum | 0.7502 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.